Sign in

CIK 0001878313

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

MAIA Biotechnology, Inc.

Sign in to watch
Ticker
MAIA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 312-416-8592
Business address
444 WEST LAKE STREET, SUITE 1700, CHICAGO, IL, 60606
Open-market buys, last 90 days
$352,317
in 5 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$352,317. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Guerrero Ramiro +$252K Director 4 filings
  2. Vitoc Vlad +$100K Chief Executive Officer 1 filing

Reading 36 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-17 Guerrero Ramiro Director Purchase +50 $4.25 $213 297,524.04
2023-02-17 Luput Cristian Director Purchase +76 $4.24 $322 278,730
2023-02-16 Smith Stan Director Purchase +62 $4.25 $264 514,171
2023-02-16 Guerrero Ramiro Director Purchase +10 $4.25 $43 297,474.04
2023-02-16 Luput Cristian Director Purchase +58 $4.25 $247 278,654
2023-02-16 Vitoc Vlad Chief Executive Officer Purchase +10 $4.25 $43 793,484
2023-02-15 Vitoc Vlad Chief Executive Officer Purchase +10 $4.25 $43 793,474
2023-02-15 Smith Stan Director Purchase +10 $4.25 $43 514,109
2023-02-14 Smith Stan Director Purchase +198 $4.25 $842 514,099
2022-09-19 Smith Stan Director Purchase +2,700 $3.69 $10K 1,424,178

Page 14 of 14 · 270 trades